Figures & data
Table 1 Annual cost data from Mckesson Canada Inc. of glaucoma medications by class of drug
Table 2 Utility rates for various medications class
Table 3 Frequency of mono-, bi-, and tri-drug therapies for treatment of glaucoma in Ontario
Table 4 Annual cost data from Ontario Drug Benefit (ODB) Formulary of glaucoma medications by class of drug
Figure 2 Difference between branded and generic medications for mono-, bi-, and tri-drug therapy for over 6 years.
![Figure 2 Difference between branded and generic medications for mono-, bi-, and tri-drug therapy for over 6 years.](/cms/asset/ea826a84-669a-4efb-8a51-d66e8f8ea5ea/dceo_a_12162189_f0002_c.jpg)
Figure 3 Percentage difference between branded and generic medications for mono-, bi-, and tri-drug therapy for over 6 years.
![Figure 3 Percentage difference between branded and generic medications for mono-, bi-, and tri-drug therapy for over 6 years.](/cms/asset/5c29b194-02c2-4bde-92c0-b2bc1d447539/dceo_a_12162189_f0003_c.jpg)
Figure 4 Difference between branded and generic medications for various medication classes over 6 years.
![Figure 4 Difference between branded and generic medications for various medication classes over 6 years.](/cms/asset/7d530e35-cfec-4b9c-ba38-ca39b54270a2/dceo_a_12162189_f0004_c.jpg)
Figure 5 Percentage difference between branded and generic medications for various medication classes for over 6 years.
![Figure 5 Percentage difference between branded and generic medications for various medication classes for over 6 years.](/cms/asset/a40753cf-3cf6-4ec2-88b0-86a17ea9d3a8/dceo_a_12162189_f0005_c.jpg)
Availability of data and materials
All data is presented within the manuscript.